GAS5 and myasthenia gravis: Finally, Xu and colleagues confirmed GAS5 down-regulation in MG CD4+ T cells, where this lncRNA was described to inhibit differentiation of Th17 cells through negative regulation of miR-23a, thus eventually contributing to the imbalance of the Th17/Tregs ratio in MG [138].